miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9. - Wikidata - thesis-toulmin - TriplyDB

miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.

miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.

http://www.wikidata.org/entity/Q35009302

about

Genetic variants in microRNA genes: impact on microRNA expression, function, and disease ApoptomiRs of Breast Cancer: Basics to Clinics MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment.Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death.Phenotypic and microRNA transcriptomic profiling of the MDA-MB-231 spheroid-enriched CSCs with comparison of MCF-7 microRNA profiling dataset.Cancer affects microRNA expression, release, and function in cardiac and skeletal muscle Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells.Transcriptomic Responses of the Heart and Brain to Anoxia in the Western Painted Turtle.Schizophrenia-Associated MIR204 Regulates Noncoding RNAs and Affects Neurotransmitter and Ion Channel Gene Sets.MiR-125b inhibits stromal cell proliferation in giant cell tumor of bone by targeting parathyroid hormone 1 receptor miR-125b Enhances IL-8 Production in Early-Onset Severe Preeclampsia by Targeting Sphingosine-1-Phosphate Lyase 1.Long non-coding RNA HOTAIR regulates cyclin J via inhibition of microRNA-205 expression in bladder cancer.CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.miR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MAP2K7.A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer.miR-520e regulates cell proliferation, apoptosis and migration in breast cancer.cel-mir-237 and its homologue, hsa-miR-125b, modulate the cellular response to ionizing radiation.Elevated microRNA-125b levels predict a worse prognosis in HER2-positive breast cancer patients Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion.Good guy or bad guy: the opposing roles of microRNA 125b in cancer Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.MicroRNA-125b predicts clinical outcome and suppressed tumor proliferation and migration in human gallbladder cancer.miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer.MiR-1224-5p acts as a tumor suppressor by targeting CREB1 in malignant gliomas.miR-1470 mediates lapatinib induced p27 upregulation by targeting c-jun.Mouse models of Down syndrome: gene content and consequences.Up-regulation of miR-582-5p regulates cellular proliferation of prostate cancer cells under androgen-deprived conditions.Fastigial nucleus stimulation regulates neuroprotection via induction of a novel microRNA, rno-miR-676-1, in middle cerebral artery occlusion rats.The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer miR-125b Suppresses Proliferation and Invasion by Targeting MCL1 in Gastric Cancer.miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer.miR-1271 inhibits ERα expression and confers letrozole resistance in breast cancer.Role of micro-RNAs in breast cancer surgery.MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.Suppression of lethal-7b and miR-125a/b Maturation by Lin28b Enables Maintenance of Stem Cell Properties in Hepatoblasts.The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.

P2860

Q27014962-9CE9662E-D529-4105-8CFA-901C83F29281 Q28072414-6FD2398E-5CB3-4513-B2AF-180E4D63EDB1 Q33585094-B249DC9C-FD05-4394-92D4-1C6C98EF3221 Q33586833-4EA8D6EE-8E7E-473B-B8DD-B4896DEB40B6 Q33906581-BE370C2E-EC8C-4282-9057-A03DF1E073BB Q34052685-71E8D14B-1CA6-4A1E-BA0B-8A266F0CAE12 Q35094742-E0CBAFD2-2A77-4924-BB86-1FC3ED3BBAE1 Q35128098-257C0A3E-9930-42E5-BB40-3B39591512F8 Q35132090-715702D0-4B8B-4AA7-9E47-A2BE09A2012E Q35550226-9480499C-6BA7-4954-90E4-0B923C2831A8 Q35684018-0AD13C4B-88D8-42A1-9434-AAE2F1E3CA81 Q35880765-F327E8AD-ACC9-4087-B7CA-1A52B17C864B Q36017184-A2B346AC-3058-48FB-AD75-6AAF6C7A774D Q36217710-D511CA5D-8188-4B27-85EE-5861C73CE554 Q36246434-FB2D1464-C026-4643-864E-43F368F06607 Q36263671-4BA36C38-2EC6-4CBF-AF48-BC62DFFCBCA6 Q36891545-27E3490F-4737-4A8A-A768-47A98A459D2E Q37109741-41BE43DA-5A3E-489B-8798-34539B2B44CC Q37392954-289040BF-ED1F-4991-BF8F-3C53B918CDC9 Q37407062-A39BCAF6-DD61-4538-B233-F563FA789BF7 Q37520983-CE5B94C2-D99D-41EE-B090-E213B50E22B1 Q37701109-EBC3E799-B5F3-4307-BAE5-5BAB4724733A Q37718496-79F5C44C-A34D-4877-92CE-567E95F5A1EF Q38207752-AC5D1EC7-2D73-4359-8BDD-A029D85589CF Q38492153-CF26B81B-800F-42F9-A038-B214B377D5AA Q38710244-9DEA2E56-EE70-42F6-81F7-955EA6EB1DC4 Q38905249-C464A2D4-0E86-4CBB-ACBE-B3F599C7B5CC Q38913363-C9398E04-9582-4BB5-8693-2ED2C4BF9B11 Q38924845-6518C6B4-24A3-436D-ADE3-E4F6AF6CCCA3 Q38931172-35013FBD-9218-4E6E-A09B-FBC1C0E5679C Q38960954-544BA740-0F6A-4D6E-AC89-38230377FA17 Q41201356-6B5EB8E9-7578-43A0-A04A-FFD4B94D3E09 Q41709315-0E1DAE14-48B9-4E32-926A-CC4823F8FCDB Q42735024-72721E09-22ED-4104-B9AD-F6B6EAA212A7 Q45992649-A89C127D-875C-44D9-9427-79206DA139CC Q47126001-040922BB-9DAE-45C8-89BE-7661EE5D5AA8 Q47728281-47CE8BEB-C032-4227-8CD9-897FEF4B56A4 Q50417171-3221C1FF-5175-4469-BF36-7E37C6A2EB88 Q52879948-7BCF18FA-D5AF-4E26-AEE8-78C0A401EFDE Q53220492-21C2142D-1CAE-46CC-B106-7D907F5F70A9

P2860

miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.

http://www.wikidata.org/entity/Q35009302

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

miR-125b acts as a tumor suppr ...... ENPEP, CK2-α, CCNJ, and MEGF9.

@ast

miR-125b acts as a tumor suppr ...... ENPEP, CK2-α, CCNJ, and MEGF9.

@en

type

label

miR-125b acts as a tumor suppr ...... ENPEP, CK2-α, CCNJ, and MEGF9.

@ast

miR-125b acts as a tumor suppr ...... ENPEP, CK2-α, CCNJ, and MEGF9.

@en

prefLabel

miR-125b acts as a tumor suppr ...... ENPEP, CK2-α, CCNJ, and MEGF9.

@ast

miR-125b acts as a tumor suppr ...... ENPEP, CK2-α, CCNJ, and MEGF9.

@en

P1433

Q35009302-0BD6ABB1-A189-4022-A93E-0ED90CBE05D5

P1476

Q35009302-593FD6BE-BCD1-4A5D-83C6-02DFE383C6A1

P2093

Q35009302-39EED6C6-319D-4A5A-910D-BD8BB1A8BB2A

Q35009302-606386D2-B93E-4AE1-9F46-8DB79543664D

Q35009302-707A920F-2332-4E72-96BD-D39CB547E264

Q35009302-78D94BA0-F88D-43FA-BE22-2060DF39FF8A

Q35009302-8C088AD4-3BB4-4798-BB96-9BBC8E5D6E00

Q35009302-945FBA80-1F96-4DB7-BFD3-32E60438371C

Q35009302-980502E9-281A-4DE0-8DB4-0692E4DA59E3

Q35009302-BA534FC9-D2BD-4AC9-8D40-8C011F552F1D

P2860

Q35009302-00071EBE-ACC0-4AB8-A82E-525E2D3D04E9

Q35009302-0528F931-1966-40E9-9D3F-45C26DDFD9F1

Q35009302-06AE6B1D-EAB4-4A33-B57A-9D5F42B43160

Q35009302-0870B83E-099A-4AC6-9CB6-0247416879EA

Q35009302-0A64D282-FB4D-48A4-B3A7-4F252A4E81FC

Q35009302-0C3EB126-AACD-4A30-8338-9460E5F76334

Q35009302-170A243E-0D3A-4372-9818-49151381017B

Q35009302-1A89995A-5B92-419E-8A4C-3EBEF7CC68ED

Q35009302-240B95C3-9F19-4E3E-90C3-3CE83B25CD21

Q35009302-268D1944-ED4E-45DB-8F6B-457C130725F7

P304

Q35009302-D2455B32-8D3A-4178-9315-2B4A2E57D7A8

P31

Q35009302-3D2014E2-9F27-4BD2-981F-A4FEB028D9B5

P356

Q35009302-20852365-25B5-4D14-BA6A-6094BBA402DC

P407

Q35009302-F0ED0BF1-AE37-4DE2-A54C-FE6D6A3E52CB

P433

Q35009302-BF2C2D14-7117-4236-9B0D-49A3F19A6E46

P478

Q35009302-CA541861-2249-427F-A715-9798F83B283D

P50

Q35009302-25C54BFA-1E73-42AE-A3D4-D1B7CD0629EF

Q35009302-382B4CAE-5D23-4451-86A5-8AAA4839EE33

Q35009302-D3537E10-86E2-4B74-A0DC-BA6CD06F47D3

Q35009302-EA8677C4-BE72-46D2-9950-5868DD593533

P577

Q35009302-6DEA64E3-DEE7-40F1-A608-C6B38885CB4A

P5875

Q35009302-6D716948-D5B8-4EAB-AFA4-F957DB6AB67A

P698

Q35009302-7B861585-6729-4BF2-A9AE-9B5417957ABF

P932

Q35009302-A45FE8F2-FEBA-4876-BA21-BCA52F5F57EC

P356

JOURNAL.PONE.0076247

P1433

P1476

miR-125b acts as a tumor suppr ...... ENPEP, CK2-α, CCNJ, and MEGF9.

@en

P2093

Ana Artero-Castro

http://www.w3.org/2001/XMLSchema#string

Andrea Feliciano

http://www.w3.org/2001/XMLSchema#string

Angels Fabra

http://www.w3.org/2001/XMLSchema#string

Cleofé Romagosa

http://www.w3.org/2001/XMLSchema#string

Francisco Vidal

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kondoh

http://www.w3.org/2001/XMLSchema#string

Jose A Leal

http://www.w3.org/2001/XMLSchema#string

Matilde E Lleonart

http://www.w3.org/2001/XMLSchema#string

P2860

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers

MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer

Aminopeptidase A is a functional target in angiogenic blood vessels

Micro-RNA regulation of the mammalian lin-28 gene during neuronal differentiation of embryonal carcinoma cells.

A biomarker that identifies senescent human cells in culture and in aging skin in vivo

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

MicroRNA-373 induces expression of genes with complementary promoter sequences

Cancer statistics, 2010

MicroRNA gene expression deregulation in human breast cancer

P304

e76247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0076247

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Josep Castellvi

Santiago Ramon y Cajal

Javier Hernandez-Losa

P577

2013-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257464707

http://www.w3.org/2001/XMLSchema#string

P698

24098452

http://www.w3.org/2001/XMLSchema#string

P932

3789742

http://www.w3.org/2001/XMLSchema#string